iTeos Therapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
iTeos Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • iTeos Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -20.1 %, a 107% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Return On Equity for 2023 was -18.4 %, a 222% decline from 2022.
  • iTeos Therapeutics, Inc. annual Return On Equity for 2022 was 15.1 %, a 73.1% decline from 2021.
  • iTeos Therapeutics, Inc. annual Return On Equity for 2021 was 56.2 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -18.4 -33.5 -222% Jan 1, 2023 Dec 31, 2023
2022 15.1 -41.1 -73.1% Jan 1, 2022 Dec 31, 2022
2021 56.2 +82.8 Jan 1, 2021 Dec 31, 2021
2020 -26.6 -113 -131% Jan 1, 2020 Dec 31, 2020
2019 86.3 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.